JAK/STAT signaling pathway affects CCR5 expression in human CD4+ T cells

Lingyun Wang1, Yunus Yukselten1, Julius Nuwagaba1

  • 1Section of Infectious Diseases, Department of Internal Medicine, Yale University, New Haven, CT, USA.

Science Advances
|March 20, 2024
PubMed

Insights

Targeting the JAK/STAT pathway with inhibitors can reduce CCR5 and CCR2 expression on CD4+ T cells. This finding is crucial for developing new strategies against R5-tropic HIV infection and advancing HIV cure research.

Area of Science:

  • Immunology
  • Virology
  • Molecular Biology

Background:

  • CCR5 is a key co-receptor for R5-tropic HIV entry into CD4+ T cells.
  • CCR5 downregulation is a potential strategy for HIV cure, but achieving this safely and effectively remains a challenge.
  • The JAK/STAT signaling pathway is implicated in various cellular processes, including immune cell function.

Purpose of the Study:

  • To investigate the association between the JAK/STAT signaling pathway and the expression of CCR5 and CCR2 in human primary CD4+ T cells.
  • To identify JAK/STAT inhibitors that can effectively reduce CCR5/CCR2 expression.
  • To assess the impact of modulating this pathway on HIV resistance.

Main Methods:

  • Treatment of primary CD4+ T cells with JAK/STAT inhibitors (e.g., tofacitinib, ruxolitinib).
  • Genetic manipulation using single and combined knockouts of JAK/STAT pathway components (JAK2, STAT3, STAT5A, STAT5B).
  • Analysis of CCR5/CCR2 expression at both RNA and protein levels, and assessment of cellular resistance to R5-tropic HIV infection.

Main Results:

  • Six of nine tested JAK/STAT inhibitors significantly reduced CCR5/CCR2 expression in CD4+ T cells.
  • Inhibitor-treated cells exhibited increased resistance to R5-tropic HIV infection.
  • Knockout of JAK2, STAT3, STAT5A, and STAT5B individually or in combination markedly decreased CCR5/CCR2 expression, confirming positive regulation by the JAK-STAT pathway.
  • Serum and glucocorticoid-regulated kinase 1 (SGK1) knockout also affected CCR2/CCR5 gene expression, suggesting its involvement.

Conclusions:

  • The JAK-STAT signaling pathway positively regulates CCR5 and CCR2 expression in CD4+ T cells.
  • Targeting this pathway with specific inhibitors offers a promising strategy for reducing HIV co-receptor expression.
  • Further research into specific JAK/STAT inhibitors and SGK1 could lead to novel therapeutic approaches for HIV cure.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.9K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
726
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K